Roger B. Cohen
1985–2025 年に発表
- 106
- 論文数
- 24,317
- 被引用数
- 66
- h 指数
- 101
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine67%
- Biochemistry, Genetics and Molecular Biology21.1%
- Immunology and Microbiology8.8%
- Engineering0.5%
- Computer Science0.3%
- Chemistry0.3%
- その他2%
トピック
- Cancer Immunotherapy and Biomarkers8.2%
- Head and Neck Cancer Studies5.4%
- Lung Cancer Treatments and Mutations5.1%
- Immune Cell Function and Interaction3.4%
- Cancer Genomics and Diagnostics2.9%
- CAR-T cell therapy research2.7%
- その他72.3%
共著者
- Charu Aggarwal33
- Corey J. Langer27
- Joshua Bauml25
- Lova Sun17
- Christine Ciunci13
- Alexander Lin11
- Gregory S. Weinstein11
- Aditi P. Singh10
- Jeffrey C. Thompson10
- John N. Lukens10
- Melina E. Marmarelis10
- Robert M. Brody10
- Wei‐Ting Hwang10
- Erica L. Carpenter9
- Ara A. Chalian8
- Bert W. O’Malley8
- Devraj Basu8
- Jason G. Newman8
- Karthik Rajasekaran7
- Samuel Swisher‐McClure7
- Steven J. Feigenberg7
- Abigail Doucette6
- Christopher H. Rassekh6
- David Shimunov6
全論文
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
著者: Pascale André, Caroline Denis, Caroline Soulas, Clarisse Bourbon-Caillet, Julie Lopez, Thomas Arnoux, Mathieu Bléry, Cécile Bonnafous, Laurent Gauthier, Ariane Morel, Benjamín Rossi, Romain Remark, Violette Breso, Elodie Bonnet, Guillaume Habif, Sophie Guia, Ana I. Lalanne, Caroline Hoffmann, Olivier Lantz, Jérôme Fayette, Agnès Boyer-Chammard, Robert Zerbib, P. Dodion, Hormas Ghadially, Maria Jure‐Kunkel, Yannis Morel, Ronald Herbst, Émilie Narni-Mancinelli, Roger B. Cohen, Éric Vivier - Cell 2018 被引用: 1,212
- T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
著者: Patrick A. Ott, Yung‐Jue Bang, Sarina A. Piha‐Paul, Albiruni R. Abdul Razak, Jaafar Bennouna, Jean‐Charles Soria, Hope S. Rugo, Roger B. Cohen, Bert H. O’Neil, Janice M. Mehnert, Juanita Lopez, Toshihiko Doi, Emilie M.J. van Brummelen, Răzvan Cristescu, Ping Yang, Kenneth Emancipator, Karen Stein, Mark Ayers, Andrew K. Joe, Jared Lunceford - Journal of Clinical Oncology 2018 被引用: 992
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
著者: James A. Bonner, Paul M. Harari, J. Giralt, N. Azarnia, Dong M. Shin, Roger B. Cohen, Christopher U. Jones, Ranjan Sur, David Raben, Jacek Jassem, Roger Ove, Merrill S. Kies, José Baselga, Hagop Youssoufian, Nadia Amellal, Eric K. Rowinsky, K. Kian Ang - New England Journal of Medicine 2006 被引用: 5,106
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
著者: Charu Aggarwal, Jeffrey C. Thompson, Taylor A. Black, Sharyn I. Katz, Ryan Fan, Stephanie S. Yee, Austin L. Chien, Tracey L. Evans, Joshua Bauml, Evan Alley, Christine Ciunci, Abigail T. Berman, Roger B. Cohen, David Lieberman, Krishna S. Majmundar, Samantha L. Savitch, Jennifer J.D. Morrissette, Wei‐Ting Hwang, Kojo S.J. Elenitoba‐Johnson, Corey J. Langer, Erica L. Carpenter - JAMA Oncology 2018 被引用: 490
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
著者: Chiun Hsu, Se‐Hoon Lee, Samuel Ejadi, Caroline Even, Roger B. Cohen, Christophe Le Tourneau, Janice M. Mehnert, Alain P. Algazi, Emilie M.J. van Brummelen, Sanatan Saraf, Pradeep Thanigaimani, Jonathan D. Cheng, Aaron R. Hansen - Journal of Clinical Oncology 2017 被引用: 471
- Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
著者: Charu Aggarwal, Amy Prawira, Scott Antonia, Osama E. Rahma, Anthony W. Tolcher, Roger B. Cohen, Yanyan Lou, Ralph J. Hauke, Nicholas J. Vogelzang, Dan P. Zandberg, Arash Rezazadeh Kalebasty, Victoria Atkinson, Alex A. Adjei, Mahesh Seetharam, Ariel E. Birnbaum, Andrew Weickhardt, Vinod Ganju, Anthony M. Joshua, Rosetta Cavallo, Linda Peng, Xiaoyu Zhang, Sanjeev Kaul, Jan Baughman, Ezio Bonvini, Paul A. Moore, S. Goldberg, Fernanda I. Arnaldez, Robert L. Ferris, Nehal J. Lakhani - Journal for ImmunoTherapy of Cancer 2022 被引用: 141
- Association Between Duration of Immunotherapy and Overall Survival in Advanced Non–Small Cell Lung Cancer
著者: Lova Sun, Benjamin Aaron Bleiberg, Wei‐Ting Hwang, Melina E. Marmarelis, Corey J. Langer, Aditi P. Singh, Roger B. Cohen, Ronac Mamtani, Charu Aggarwal - JAMA Oncology 2023 被引用: 148
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
著者: James A. Bonner, Paul M. Harari, J. Giralt, Roger B. Cohen, Christopher U. Jones, Ranjan Sur, David Raben, José Baselga, Sharon A. Spencer, Junming Zhu, Hagop Youssoufian, Eric K. Rowinsky, K. Kian Ang - The Lancet Oncology 2009 被引用: 1,974
- Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy
著者: Jeffrey C. Thompson, Erica L. Carpenter, Benjamin A. Silva, J Rosenstein, Austin L. Chien, Katie Quinn, Carin R. Espenschied, Allysia J. Mak, Lesli A. Kiedrowski, Martina I. Lefterova, Rebecca J. Nagy, Sharyn I. Katz, Stephanie S. Yee, Taylor A. Black, Aditi P. Singh, Christine Ciunci, Joshua Bauml, Roger B. Cohen, Corey J. Langer, Charu Aggarwal - JCO Precision Oncology 2021 被引用: 105
- Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
著者: Stephen Bagley, Shawn Kothari, Charu Aggarwal, Joshua Bauml, Evan Alley, Tracey L. Evans, John A. Kosteva, Christine Ciunci, Peter Gabriel, Jeffrey C. Thompson, Susan Stonehouse-Lee, Victoria Sherry, Elizabeth Gilbert, Beth Eaby‐Sandy, Faith Mutale, Gloria A DiLullo, Roger B. Cohen, Anil Vachani, Corey J. Langer - Lung Cancer 2017 被引用: 529
- Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer
著者: Joshua Bauml, Rosemarie Mick, Christine Ciunci, Charu Aggarwal, Christiana Davis, Tracey L. Evans, Charuhas Deshpande, Linda Miller, Pooja Patel, Evan Alley, Christina Knepley, Faith Mutale, Roger B. Cohen, Corey J. Langer - JAMA Oncology 2019 被引用: 320
- Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma
著者: Bert H. O’Neil, John M. Wallmark, David Lorente, Élena Elez, Judith Raimbourg, Carlos Gomez‐Roca, Samuel Ejadi, Sarina A. Piha‐Paul, Mark N. Stein, Albiruni R. Abdul Razak, Katia Dotti, Armando Santoro, Roger B. Cohen, M. Gould, Sanatan Saraf, Karen Stein, Sae‐Won Han - PLoS ONE 2017 被引用: 305
- Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
著者: Marshall R. Posner, Diáne Hershock, C. Blajman, E. Mickiewicz, Eric Winquist, Vera Gorbounova, Sergei Tjulandin, Dong M. Shin, Kevin J. Cullen, Thomas J. Ervin, Barbara A. Murphy, Luis E. Raez, Roger B. Cohen, Monica B. Spaulding, Roy B. Tishler, Berta Roth, Rosana del Carmen Viroglio, Varagur Venkatesan, И. С. Романов, Sanjiv S. Agarwala, K. William Harter, Matthew Dugan, Anthony J. Cmelak, Arnold M. Markoe, Paul W. Read, Lynn M. Steinbrenner, A. Dimitrios Colevas, Charles M. Norris, Robert I. Haddad - New England Journal of Medicine 2007 被引用: 1,704
- Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
著者: Julie K. Jadlowsky, Elizabeth O. Hexner, Amy Marshall, Stephan A. Grupp, Noelle V. Frey, James L. Riley, Elizabeth Veloso, Holly McConville, Walter Rogal, Cory Czuczman, Wei‐Ting Hwang, Yimei Li, Rachel Leskowitz, Olivia Farrelly, Jayashree Karar, Shannon Christensen, Julie S. Barber-Rotenberg, Avery L. Gaymon, Naomi Aronson, Wendy Bernstein, J. Joseph Melenhorst, Aoife M. Roche, J.K. Everett, Sonja A. Zolnoski, Alexander McFarland, Shantan Reddy, Angelina Petrichenko, Emma J. Cook, Carole Lee, Vanessa Gonzalez, Kathleen A. Alexander, Irina Kulikovskaya, Ángel Ramírez-Fernández, Janna Minehart, Marco Ruella, Saar Gill, Stephen J. Schuster, Adam D. Cohen, Alfred L. Garfall, Payal D. Shah, David L. Porter, Shannon L. Maude, Bruce L. Levine, Don L. Siegel, Anne Chew, S.J. McKenna, Lester Lledo, Megan M. Davis, Gabriela Plesa, Friederike Herbst, Edward A. Stadtmauer, Pablo Tebas, Amanda M. DiNofia, A. Haas, Naomi B. Haas, Regina M. Myers, Donald M. O’Rourke, Jakub Svoboda, János L. Tanyi, Richard Aplenc, Jeffrey M. Jacobson, Andrew H. Ko, Roger B. Cohen, Carl H. June, Frederic D. Bushman, Joseph A. Fraietta - Nature Medicine 2025 被引用: 71
- Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma
著者: Roger B. Cohen, Jean‐Pierre Delord, Toshihiko Doi, Sarina A. Piha‐Paul, Stephen V. Liu, Jill Gilbert, Alain P. Algazi, Silvia Damian, Ruey‐Long Hong, Christophe Le Tourneau, Daphne Day, Andréa Varga, Elena Élez, John M. Wallmark, Sanatan Saraf, Pradeep Thanigaimani, Jonathan D. Cheng, Bhumsuk Keam - American Journal of Clinical Oncology 2018 被引用: 206
- Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
著者: Charu Aggarwal, Melina E. Marmarelis, Wei‐Ting Hwang, Dylan Scholes, Tara McWilliams, Aditi P. Singh, Lova Sun, John A. Kosteva, Michael R. Costello, Roger B. Cohen, Corey J. Langer, Abigail Doucette, Peter Gabriel, Lawrence N. Shulman, Katharine A. Rendle, Jeffrey C. Thompson, Justin E. Bekelman, Erica L. Carpenter - JCO Precision Oncology 2023 被引用: 44
- 854O INTERLINK-1: Phase III study of cetuximab (CTX) ± monalizumab (M) in participants (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) with disease progression on/after platinum chemotherapy (CT) and previously treated with an immune checkpoint inhibitor (ICI)
著者: Jérôme Fayette, Lisa Licitra, Kevin J. Harrington, Robert I. Haddad, Lillian L. Siu, Yi‐Chun Liu, Makoto Tahara, J-P. Machiels, Danny Rischin, Tanguy Y. Seiwert, Robert L. Ferris, Ulrich Keilholz, Amanda Psyrri, Bhumsuk Keam, Paolo Bossi, Robert Metcalf, Oscar K. Serrano, Paramjit Kaur, Dario Ruscica, Roger B. Cohen - Annals of Oncology 2023 被引用: 32
- A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus–Related Squamous Cell Carcinoma of the Oropharynx
著者: Samuel Swisher‐McClure, John N. Lukens, Charu Aggarwal, Peter H. Ahn, Devraj Basu, Joshua Bauml, Robert M. Brody, Ara A. Chalian, Roger B. Cohen, Alireza Fotouhi-Ghiam, Geoffrey A. Geiger, Jared Gershowitz, Virginia A. LiVolsi, Nandita Mitra, Kathleen T. Montone, Jason G. Newman, Eric Ojerholm, Bert W. O’Malley, Karthik Rajasekaran, Erik X. Tan, Gregory S. Weinstein, Alexander Lin - International Journal of Radiation Oncology*Biology*Physics 2019 被引用: 170
- Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer
著者: Charu Aggarwal, Jeffrey C. Thompson, Austin L. Chien, Katie Quinn, Wei‐Ting Hwang, Taylor A. Black, Stephanie S. Yee, Theresa Christensen, Michael J. LaRiviere, Benjamin A. Silva, Kimberly C. Banks, Rebecca J. Nagy, Elena Helman, Abigail T. Berman, Christine Ciunci, Aditi P. Singh, Jeffrey S. Wasser, Joshua Bauml, Corey J. Langer, Roger B. Cohen, Erica L. Carpenter - Clinical Cancer Research 2020 被引用: 103
- Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors
著者: Jeffrey R. Infante, E. Claire Dees, Anthony J. Olszanski, Shyeilla V. Dhuria, Suman Sen, Scott B. Cameron, Roger B. Cohen - Journal of Clinical Oncology 2014 被引用: 209
- Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
著者: Lova Sun, Miles Hsu, Roger B. Cohen, Corey J. Langer, Ronac Mamtani, Charu Aggarwal - JAMA Oncology 2021 被引用: 85
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
著者: Razelle Kurzrock, Steven I. Sherman, Douglas W. Ball, Arlene A. Forastiere, Roger B. Cohen, Ranee Mehra, David G. Pfister, Ezra E.W. Cohen, Linda Janisch, Forlisa Nauling, David S. Hong, Chaan S. Ng, Lei Ye, Robert F. Gagel, John Frye, Thomas Müller, Mark J. Ratain, Ravi Salgia - Journal of Clinical Oncology 2011 被引用: 551
- Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
著者: Jeffrey C. Thompson, Stephanie S. Yee, Andrea B. Troxel, Samantha L. Savitch, Ryan Fan, David Balli, David Lieberman, Jennifer D. Morrissette, Tracey L. Evans, Joshua Bauml, Charu Aggarwal, John A. Kosteva, Evan Alley, Christine Ciunci, Roger B. Cohen, Stephen Bagley, Susan Stonehouse-Lee, Victoria Sherry, Elizabeth Gilbert, Corey J. Langer, Anil Vachani, Erica L. Carpenter - Clinical Cancer Research 2016 被引用: 328
- Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
著者: Charu Aggarwal, Roger B. Cohen, Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Dawson Knoblock, Joshua Bauml, Gregory S. Weinstein, Alexander Lin, Jean Boyer, Lindsay Sakata, Sophie Seine Xuan Tan, Aubrey Anton, Kelsie Dickerson, Drishty Mangrolia, Russell Vang, Michael Dallas, Sandra Oyola, Susan Duff, Mark T. Esser, Rakesh Kumar, David B. Weiner, Ildiko Csiki, Mark L. Bagarazzi - Clinical Cancer Research 2018 被引用: 144
